Global Cell Counting market overview 2024, Forecast To 2033
26 Jan, 2024
The cell counting market has experienced robust growth in recent years, increasing from $9.96 billion in 2023 to $10.87 billion in 2024, reflecting a compound annual growth rate (CAGR) of 9.1%. This growth in the historic period is attributed to advancements in biomedical research, heightened clinical diagnostics, an expanding pharmaceutical industry, intensified cancer research, and a rising aging population. Looking ahead to 2028, the market is anticipated to continue its strong trajectory, reaching $15.3 billion with a CAGR of 8.9%. This forecasted growth is driven by a heightened focus on precision medicine, the growing adoption of regenerative medicine, increased point-of-care testing, and expanded stem cell research. Notable trends include technological advancements, product innovations, AI integration, automation technology solutions, and strategic collaborations.
Global Cell Counting Market Key Driver
The escalating prevalence of cancer globally is a major factor expected to fuel the growth of the cell counting market. Factors such as changing lifestyles, unhealthy body weight maintenance, and chronic infections contribute to cancer risk. In 2022, the American Cancer Society projects 1.9 million new cancer cases and 609,360 deaths in the United States, indicating a growing trend in chronic diseases. The need for cell counting rises with the increasing incidence of cancer, making it a pivotal factor driving the cell counting market in 2023, 2024, and beyond.
Get A Free Sample Of The Global Cell Counting Market ReportGlobal Cell Counting Market Segments
The global cell counting market covered in this report is segmented –
1) By Consumables And Accessories: Media, Sera And Reagents, Assay Kits, Microplates, Accessories, Other Consumables
2) By Product: Spectrophotometers, Single-Mode Readers, Multi-Mode Readers, Cell Counters, Automated Cell Counters, Hemocytometers, Manual Cell Counters, Flow Cytometers, Hematology Analyzers
3) By Application: Research Applications, Clinical And Diagnostic Applications, Industrial Applications
4) By End-User: Hospitals And Diagnostic, Research Institutions, Pharmaceutical And Biotechnology Companies, Other End-Users
Major Cell Counting Industry Players
Thermo Fisher Scientific Inc., Merck KGaA, PerkinElmer Inc., Bio-Rad Laboratories Inc., Danaher Corporation, Olympus Corporation, HORIBA Ltd., Logos Biosystems Inc., Becton Dickinson and Company, GE Healthcare, Agilent Technologies Inc., BioTek Instruments Inc., DeNovix Inc., Sysmex Corporation, Nexcelom Bioscience LLC, Beckman Coulter Inc., Roche Diagnostics International Ltd., Miltenyi Biotec GmbH, AccuBioTech Co. Ltd., ChemoMetec A/S, Countstar Microscopy Systems, Luminex Corporation, NanoEnTek Inc., Partec GmbH, Advanced Instruments Inc., Analytik Jena AG, Integra Biosciences AG, Meridian Bioscience Inc., Promega Corporation, Sartorius AG
Get The Full Global Cell Counting Market Report
Cell Counting Market Overview
Cell counting refers to any of techniques used for counting cells or quantification of cells in the life sciences for diagnosis and treatment. Cell counting is used in monitoring cell health and proliferation rate assessing immortalization or transformation, transfection or infection, seeding cells for subsequent experiments, and preparing for cell-based assays.
Cell Counting Global Market Report 2023 provides data on the global cell counting market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The cell counting market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.